Cytosystems Limited

Overview

Legal name

CYTOSYSTEMS LIMITED

Region

Scotland

Registered address

Unknown

Insolvency history

Yes

Company events

Reference milestones and recent Companies House filing stream events.

2 events

07 Apr

2026

Gazette Dissolved Liquidation

Gazette

GAZ2 | Transaction MzUxNDczMTUwN2FkaXF6a2N4 | Paper/PDF filed

Published 08 Apr 2026 22:55

25 Nov

2004

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2015

Funded years

2015, 2019

Age at first award

10 years

Projects

2019 EU-Funded Lead participant

Enhancing the accuracy and efficiency of cytology with artificial intelligence powered analysis

1 Aug 2019 to 31 Jan 2021

Awarded

£216,054

Total cost £360,091

Cytosystems Ltd in conjunction with Pathognomics and Visio-Pharm are developing a laboratory based test called BladderLight. The BladderLight test assesses whether a urine sample taken from patients attending for initial diagnosis or for monitoring for recurrence of bladder cancer is indicative of patients having bladder cancer / urothelial carcinoma or n...

2015 Collaborative R&D Lead participant

Stratification of patients with bladder cancer for cystoscopic surveillance

1 Oct 2015 to 31 Jul 2017

Awarded

£290,467

Total cost £484,111

Cytosystems Ltd has been researching the potential to assess bladder cancer by means of a urine test. Its research over a 6 year period has led to a greater understanding of the challenges of collecting and processing urine samples and detecting the presence of cancerous cells. This project will allow the urine collection and processing to be easily carri...

Product types

Collaborative R&D EU-Funded